NEW DELHI: Dr Dangs Lab has successfully conducted screening, safety and several immunogenicity tests for all the three phases of trial for Biological E’s Corbevax - the first indigenously developed protein-subunit vaccine against COVID-19 and the third vaccine ( after Covaxin and ZyCoV-D) to be made-in-India. Corbevax utilizes the receptor-binding domain from the spike protein as the vaccine antigen.
The timely and high quality reporting of the lab tests for the Corbevax trials - conducted at Dr DANGS LABS in New Delhi - was the result of relentless hard work by the team carried out with clockwork precision under the close watch of experts , featuring deeply orchestrated accurate lab assays, project management, tech transfers and efficient bio-repository management. Rigorous quality benchmarks, such as GCLP guidelines as mandated by regulatory authorities, were adhered to.
“We at Dr. DANGS LABS are humbled and elated to be part of this important milestone. The testing for the Corbevax trial called for close coordination with participating investigative sites, principal investigators as well as efficient handling of pan-India logistics - and the team pulled it off with characteristic efficiency. Proud to have been chosen as the central lab of choice to provide end to end services ", said Dr Arjun Dang, CEO of Dr DANGS LAB.
The development has come in the wake of the Drug Controller General of India (DCGI) approving two new Covid-19 vaccines and one anti-viral drug for emergency use on Tuesday.
Dr DANGS LAB is an NCR based premium lab chain recognized for its ethos of personalised and high quality diagnostic services. It also partners with various institutes and companies for academic research and clinical trials.
*This Press Release is published by VOH team.*
Medanta Gurugram organizes initiatives to strengthen awareness around colorectal
Metropolis' MedEngage Scholarship Program recognizes 250 medical students with S
AMRI Hospitals Kolkata set to be acquired by The Manipal Group
Dr Nitish Shetty appointed CEO of Aster DM Healthcare (India Business)
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?View All